Bextra (generic name valdecoxib), a non-steroidal anti-inflammatory (NSAID) used to relieve symptoms of osteoarthritis and rheumatoid arthritis, was pulled from the market in 2005 because of links to serious cardiovascualar problems in users of the drug. This section contains health and legal information on Bextra.